Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Revenue of Tactile Systems Technology, Inc. (TCMD)
Revenue in 2023 (TTM): $274.42 M
According to Tactile Systems Technology, Inc.'s latest financial reports the company's current revenue (TTM) is $274.42 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Tactile Systems Technology, Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $274.42 M | $195.13 M | $22.31 M | $15.77 M | $28.52 M |
| 2022 | $246.79 M | $175.98 M | $-9,205,000 | $-15,473,000 | $-17,866,000 |
| 2021 | $208.06 M | $148.21 M | $1.92 M | $-2,293,000 | $-11,811,000 |
| 2020 | $187.13 M | $132.81 M | $-834,000 | $-2,261,000 | $-620,000 |
| 2019 | $189.49 M | $134.24 M | $14.04 M | $11.13 M | $10.97 M |
| 2018 | $143.75 M | $102.26 M | $2.99 M | $3.48 M | $6.62 M |
| 2017 | $109.28 M | $80.27 M | $3.9 M | $4.19 M | $5.86 M |
| 2016 | $84.54 M | $61.6 M | $5.07 M | $4.31 M | $2.88 M |
| 2015 | $62.87 M | $45.96 M | $4.28 M | $3.26 M | $1.39 M |
| 2014 | $47.74 M | $35.02 M | $4.51 M | $3.8 M | $2.07 M |
| 2013 | $37.18 M | $27.4 M | $2.97 M | $2.38 M | $3.16 M |